[10-Q] CME GROUP INC. Quarterly Earnings Report

Q: What were CME (CME) Q3 2025 revenue and EPS?

Revenue was $1,537.6 million ; diluted EPS was $2.49 .

Q: How did CME's revenue mix change in Q3 2025?

Clearing and transaction fees were $1,227.9 million (down year over year), while market data grew to $202.5 million (up 14% ).

Q: What was CME’s operating margin in Q3 2025?

Operating margin was 63.3% on operating income of $972.6 million .

Q: How much operating cash flow did CME generate year-to-date 2025?

Net cash provided by operating activities was $3,143.2 million for the nine months ended September 30, 2025.

Q: What capital returns did CME make in 2025 so far?

Dividends totaled $3.75 per share YTD; CME repurchased 32,265 shares for $8.2 million .

Q: What is CME’s current debt profile?

Long‑term debt was $3,421.3 million . CME retired $750.0 million due 2025 and issued $750.0 million due 2030.

Q: What is the status of the OSTTRA transaction?

On October 10, 2025 , CME completed the sale of OSTTRA (EV $3.1 billion split 50/50) and expects a ~ $300.0 million gain in Q4.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

10-Q

Rhea-AI Filing Summary

CME Group Inc. reported Q3 2025 results with total revenue of $1,537.6 million versus $1,584.4 million a year ago as lower futures and options activity reduced clearing and transaction fees. Operating income was $972.6 million with a 63.3% operating margin. Net income was $908.0 million, and diluted EPS was $2.49.

Market data and information services grew to $202.5 million (up 14% year over year), partly offsetting softer trading revenues. Non‑operating income of $204.4 million reflected high investment income driven by reinvestment of performance bond collateral, net of distributions to clearing members.

Year‑to‑date, operating cash flow reached $3,143.2 million. The company paid dividends of $1.25 per share in Q3 (total $3.75 per share YTD) and repurchased 32,265 shares for $8.2 million. CME refinanced debt—retiring $750.0 million due 2025 and adding $750.0 million due 2030—bringing long‑term debt to $3,421.3 million. Subsequent event: on October 10, 2025, CME and S&P Global completed the sale of OSTTRA (EV $3.1 billion split 50/50); CME expects to recognize a ~$300.0 million gain in Q4 2025.

Insights

Stable profitability; mix shift to market data; OSTTRA gain ahead.

CME Group delivered strong margins despite a 3% revenue dip to $1,537.6 million as lower Q3 volatility reduced clearing fees. Market data rose to $202.5 million (up 14% year over year), supporting earnings quality beyond transaction-driven revenue.

Non-operating items show large investment income tied to performance bond cash, offset by distributions, producing $204.4 million in non-operating income. Leverage remains moderate: long-term debt at $3,421.3 million after refinancing $750.0 million into notes due 2030.

The completed OSTTRA sale on October 10, 2025 (EV $3.1 billion, 50/50 split) is expected to add an estimated $300.0 million gain in Q4. Actual impact will depend on final accounting and will appear in subsequent filings.

10/24/2025 - 02:07 PM

000115637512/312025Q3false360,596,6476258131,2874139.29.06.56.3983.21,024.3——0.010.0110,00010,0004,5844,5844,5844,5840.010.011,000,0001,000,000359,849359,602359,849359,6020.010.013333331.251.153.753.45750.0750.0500.0750.0750.0700.03/15/20303/15/20256/15/20283/15/20329/15/20436/15/20484.403.003.752.655.304.15750.0500.0750.0700.03/15/20256/15/20289/15/20436/15/2048xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purecme:years00011563752025-01-012025-09-300001156375us-gaap:CommonClassAMember2025-10-080001156375cme:ClassBCommonStockClassB1Member2025-10-080001156375cme:ClassBCommonStockClassB2Member2025-10-080001156375cme:ClassBCommonStockClassB3Member2025-10-080001156375cme:ClassBCommonStockClassB4Member2025-10-0800011563752025-09-3000011563752024-12-310001156375us-gaap:CommonClassAMember2025-09-300001156375us-gaap:CommonClassAMember2024-12-310001156375us-gaap:CommonClassBMember2025-09-300001156375us-gaap:CommonClassBMember2024-12-310001156375us-gaap:PreferredStockMember2025-09-300001156375us-gaap:PreferredStockMember2024-12-310001156375cme:ClearingandtransactionfeesMember2025-07-012025-09-300001156375cme:ClearingandtransactionfeesMember2024-07-012024-09-300001156375cme:ClearingandtransactionfeesMember2025-01-012025-09-300001156375cme:ClearingandtransactionfeesMember2024-01-012024-09-300001156375cme:MarketDataMember2025-07-012025-09-300001156375cme:MarketDataMember2024-07-012024-09-300001156375cme:MarketDataMember2025-01-012025-09-300001156375cme:MarketDataMember2024-01-012024-09-300001156375cme:OtherRevenueMember2025-07-012025-09-300001156375cme:OtherRevenueMember2024-07-012024-09-300001156375cme:OtherRevenueMember2025-01-012025-09-300001156375cme:OtherRevenueMember2024-01-012024-09-3000011563752025-07-012025-09-3000011563752024-07-012024-09-3000011563752024-01-012024-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:PreferredStockMember2024-12-310001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassAMember2024-12-310001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassBMember2024-12-310001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-12-310001156375us-gaap:RetainedEarningsMember2024-12-310001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001156375us-gaap:ParentMember2024-12-310001156375us-gaap:RetainedEarningsMember2025-01-012025-09-300001156375us-gaap:ParentMember2025-01-012025-09-300001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassAMember2025-01-012025-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-01-012025-09-300001156375us-gaap:CommonClassAMember2025-01-012025-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:PreferredStockMember2025-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassAMember2025-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassBMember2025-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-09-300001156375us-gaap:RetainedEarningsMember2025-09-300001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300001156375us-gaap:ParentMember2025-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:PreferredStockMember2025-06-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassAMember2025-06-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassBMember2025-06-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-06-300001156375us-gaap:RetainedEarningsMember2025-06-300001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001156375us-gaap:ParentMember2025-06-300001156375us-gaap:RetainedEarningsMember2025-07-012025-09-300001156375us-gaap:ParentMember2025-07-012025-09-300001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassAMember2025-07-012025-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-07-012025-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:PreferredStockMember2023-12-310001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassAMember2023-12-310001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassBMember2023-12-310001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-12-310001156375us-gaap:RetainedEarningsMember2023-12-310001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001156375us-gaap:ParentMember2023-12-310001156375us-gaap:RetainedEarningsMember2024-01-012024-09-300001156375us-gaap:ParentMember2024-01-012024-09-300001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassAMember2024-01-012024-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-01-012024-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:PreferredStockMember2024-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassAMember2024-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassBMember2024-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-09-300001156375us-gaap:RetainedEarningsMember2024-09-300001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001156375us-gaap:ParentMember2024-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:PreferredStockMember2024-06-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassAMember2024-06-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassBMember2024-06-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-06-300001156375us-gaap:RetainedEarningsMember2024-06-300001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001156375us-gaap:ParentMember2024-06-300001156375us-gaap:RetainedEarningsMember2024-07-012024-09-300001156375us-gaap:ParentMember2024-07-012024-09-300001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMemberus-gaap:CommonClassAMember2024-07-012024-09-300001156375us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-07-012024-09-3000011563752023-12-3100011563752024-09-300001156375cme:InterestRateMembercme:ClearingandtransactionfeesMember2025-07-012025-09-300001156375cme:InterestRateMembercme:ClearingandtransactionfeesMember2024-07-012024-09-300001156375cme:InterestRateMembercme:ClearingandtransactionfeesMember2025-01-012025-09-300001156375cme:InterestRateMembercme:ClearingandtransactionfeesMember2024-01-012024-09-300001156375cme:EquitiesMembercme:ClearingandtransactionfeesMember2025-07-012025-09-300001156375cme:EquitiesMembercme:ClearingandtransactionfeesMember2024-07-012024-09-300001156375cme:EquitiesMembercme:ClearingandtransactionfeesMember2025-01-012025-09-300001156375cme:EquitiesMembercme:ClearingandtransactionfeesMember2024-01-012024-09-300001156375us-gaap:ForeignExchangeMembercme:ClearingandtransactionfeesMember2025-07-012025-09-300001156375us-gaap:ForeignExchangeMembercme:ClearingandtransactionfeesMember2024-07-012024-09-300001156375us-gaap:ForeignExchangeMembercme:ClearingandtransactionfeesMember2025-01-012025-09-300001156375us-gaap:ForeignExchangeMembercme:ClearingandtransactionfeesMember2024-01-012024-09-300001156375cme:AgriculturalcommodityMembercme:ClearingandtransactionfeesMember2025-07-012025-09-300001156375cme:AgriculturalcommodityMembercme:ClearingandtransactionfeesMember2024-07-012024-09-300001156375cme:AgriculturalcommodityMembercme:ClearingandtransactionfeesMember2025-01-012025-09-300001156375cme:AgriculturalcommodityMembercme:ClearingandtransactionfeesMember2024-01-012024-09-300001156375cme:EnergyMembercme:ClearingandtransactionfeesMember2025-07-012025-09-300001156375cme:EnergyMembercme:ClearingandtransactionfeesMember2024-07-012024-09-300001156375cme:EnergyMembercme:ClearingandtransactionfeesMember2025-01-012025-09-300001156375cme:EnergyMembercme:ClearingandtransactionfeesMember2024-01-012024-09-300001156375cme:MetalMembercme:ClearingandtransactionfeesMember2025-07-012025-09-300001156375cme:MetalMembercme:ClearingandtransactionfeesMember2024-07-012024-09-300001156375cme:MetalMembercme:ClearingandtransactionfeesMember2025-01-012025-09-300001156375cme:MetalMembercme:ClearingandtransactionfeesMember2024-01-012024-09-300001156375cme:BrokerTecFixedIncomeMembercme:ClearingandtransactionfeesMember2025-07-012025-09-300001156375cme:BrokerTecFixedIncomeMembercme:ClearingandtransactionfeesMember2024-07-012024-09-300001156375cme:BrokerTecFixedIncomeMembercme:ClearingandtransactionfeesMember2025-01-012025-09-300001156375cme:BrokerTecFixedIncomeMembercme:ClearingandtransactionfeesMember2024-01-012024-09-300001156375cme:EBSForeignExchangeMembercme:ClearingandtransactionfeesMember2025-07-012025-09-300001156375cme:EBSForeignExchangeMembercme:ClearingandtransactionfeesMember2024-07-012024-09-300001156375cme:EBSForeignExchangeMembercme:ClearingandtransactionfeesMember2025-01-012025-09-300001156375cme:EBSForeignExchangeMembercme:ClearingandtransactionfeesMember2024-01-012024-09-300001156375us-gaap:InterestRateSwapMembercme:ClearingandtransactionfeesMember2025-07-012025-09-300001156375us-gaap:InterestRateSwapMembercme:ClearingandtransactionfeesMember2024-07-012024-09-300001156375us-gaap:InterestRateSwapMembercme:ClearingandtransactionfeesMember2025-01-012025-09-300001156375us-gaap:InterestRateSwapMembercme:ClearingandtransactionfeesMember2024-01-012024-09-300001156375us-gaap:TransferredAtPointInTimeMember2025-07-012025-09-300001156375us-gaap:TransferredAtPointInTimeMember2024-07-012024-09-300001156375us-gaap:TransferredAtPointInTimeMember2025-01-012025-09-300001156375us-gaap:TransferredAtPointInTimeMember2024-01-012024-09-300001156375us-gaap:TransferredOverTimeMember2025-07-012025-09-300001156375us-gaap:TransferredOverTimeMember2024-07-012024-09-300001156375us-gaap:TransferredOverTimeMember2025-01-012025-09-300001156375us-gaap:TransferredOverTimeMember2024-01-012024-09-300001156375cme:OnetimechargesandmiscellaneousrevenuesMember2025-07-012025-09-300001156375cme:OnetimechargesandmiscellaneousrevenuesMember2024-07-012024-09-300001156375cme:OnetimechargesandmiscellaneousrevenuesMember2025-01-012025-09-300001156375cme:OnetimechargesandmiscellaneousrevenuesMember2024-01-012024-09-300001156375us-gaap:FederalReserveBankAdvancesMember2025-09-300001156375cme:InterestFromPerformanceBondsMember2025-01-012025-09-300001156375cme:InterestFromPerformanceBondsMember2025-07-012025-09-300001156375cme:InterestFromPerformanceBondsMember2024-07-012024-09-300001156375cme:InterestFromPerformanceBondsMember2024-01-012024-09-300001156375cme:ExpenseRelatedToPerformanceBondsMember2025-07-012025-09-300001156375cme:ExpenseRelatedToPerformanceBondsMember2025-01-012025-09-300001156375cme:ExpenseRelatedToPerformanceBondsMember2024-07-012024-09-300001156375cme:ExpenseRelatedToPerformanceBondsMember2024-01-012024-09-300001156375us-gaap:CustomerRelationshipsMember2025-09-300001156375us-gaap:CustomerRelationshipsMember2024-12-310001156375us-gaap:DevelopedTechnologyRightsMember2025-09-300001156375us-gaap:DevelopedTechnologyRightsMember2024-12-310001156375us-gaap:OtherIntangibleAssetsMember2025-09-300001156375us-gaap:OtherIntangibleAssetsMember2024-12-310001156375us-gaap:FiniteLivedIntangibleAssetsMember2025-09-300001156375us-gaap:FiniteLivedIntangibleAssetsMember2024-12-310001156375us-gaap:TradeNamesMember2025-09-300001156375us-gaap:TradeNamesMember2024-12-310001156375cme:A750.0MillionFixedRateNotesDueMarch2025InterestEqualTo3.00Member2025-09-300001156375cme:A750.0MillionFixedRateNotesDueMarch2025InterestEqualTo3.00Member2024-12-3100011563752015-03-012015-03-310001156375cme:A750MillionFixedRateNotesDueMarch2030InterestEqualTo4.4Domain2025-09-300001156375cme:A750MillionFixedRateNotesDueMarch2030InterestEqualTo4.4Domain2024-12-310001156375cme:A750.0MillionFixedRateNotesDueMarch2030InterestEqualTo4.4Abstract2025-09-300001156375cme:A750.0MillionFixedRateNotesDueMarch2030InterestEqualTo4.4Abstract2024-12-310001156375cme:A7500MillionFixedRateNotesDueMarch2032InterestEqualTo265Member2025-09-300001156375cme:A7500MillionFixedRateNotesDueMarch2032InterestEqualTo265Member2024-12-310001156375cme:A750.0millionFixedRateNotesDueSeptember2043InterestEqualTo5.3Member2025-09-300001156375cme:A750.0millionFixedRateNotesDueSeptember2043InterestEqualTo5.3Member2024-12-310001156375cme:A700.0MillionFixedRateNotesDueJune2048InterestEqualTo4.15MemberDomainDomain2025-09-300001156375cme:A700.0MillionFixedRateNotesDueJune2048InterestEqualTo4.15MemberDomainDomain2024-12-3100011563752013-09-012013-09-300001156375cme:A500.0MillionFixedRateNotesDueJune2028InterestEqualTo3.75Domain2025-09-300001156375cme:A750MillionFixedRateNotesDueMarch2030InterestEqualTo4.4Domain2025-01-012025-09-300001156375cme:A750.0MillionFixedRateNotesDueMarch2025InterestEqualTo3.00Member2025-01-012025-09-300001156375cme:A500.0MillionFixedRateNotesDueJune2028InterestEqualTo3.75Domain2025-01-012025-09-300001156375cme:A7500MillionFixedRateNotesDueMarch2032InterestEqualTo265Member2025-01-012025-09-300001156375cme:A750.0millionFixedRateNotesDueSeptember2043InterestEqualTo5.3Member2025-01-012025-09-300001156375cme:A700.0MillionFixedRateNotesDueJune2048InterestEqualTo4.15MemberDomainDomain2025-01-012025-09-300001156375cme:FamilyFarmerAndRanchersProtectionFundMember2025-09-300001156375cme:FamilyFarmerAndRanchersProtectionFundMember2025-01-012025-09-300001156375us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-12-310001156375us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-12-310001156375us-gaap:CashFlowHedgingMember2024-12-310001156375us-gaap:ForeignCurrencyGainLossMember2024-12-310001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001156375us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-01-012025-09-300001156375us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-09-300001156375us-gaap:CashFlowHedgingMember2025-01-012025-09-300001156375us-gaap:ForeignCurrencyGainLossMember2025-01-012025-09-300001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-09-300001156375us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-09-300001156375us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-09-300001156375us-gaap:CashFlowHedgingMember2025-09-300001156375us-gaap:ForeignCurrencyGainLossMember2025-09-300001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300001156375us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310001156375us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001156375us-gaap:CashFlowHedgingMember2023-12-310001156375us-gaap:ForeignCurrencyGainLossMember2023-12-310001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001156375us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-09-300001156375us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-09-300001156375us-gaap:CashFlowHedgingMember2024-01-012024-09-300001156375us-gaap:ForeignCurrencyGainLossMember2024-01-012024-09-300001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001156375us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-09-300001156375us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-09-300001156375us-gaap:CashFlowHedgingMember2024-09-300001156375us-gaap:ForeignCurrencyGainLossMember2024-09-300001156375us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001156375us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2025-09-300001156375us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2025-09-300001156375us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2025-09-300001156375us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2025-09-300001156375us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MutualFundMember2025-09-300001156375us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MutualFundMember2025-09-300001156375us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MutualFundMember2025-09-300001156375us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MutualFundMember2025-09-300001156375us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2025-09-300001156375us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2025-09-300001156375us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2025-09-300001156375us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2025-09-300001156375us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-09-300001156375us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-09-300001156375us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-09-300001156375us-gaap:FairValueMeasurementsRecurringMember2025-09-300001156375us-gaap:FairValueInputsLevel2Membercme:A750MillionFixedRateNotesDueMarch2030InterestEqualTo4.4Domain2025-09-300001156375us-gaap:FairValueInputsLevel2Membercme:A750.0MillionFixedRateNotesDueMarch2030InterestEqualTo4.4Member2025-09-300001156375us-gaap:FairValueInputsLevel2Membercme:A7500MillionFixedRateNotesDueMarch2032InterestEqualTo265Member2025-09-300001156375us-gaap:FairValueInputsLevel2Membercme:A750.0millionFixedRateNotesDueSeptember2043InterestEqualTo5.3Member2025-09-300001156375us-gaap:FairValueInputsLevel2Membercme:A700.0MillionFixedRateNotesDueJune2048InterestEqualTo4.15MemberDomainDomain2025-09-300001156375us-gaap:FairValueInputsLevel2Membercme:A750.0MillionFixedRateNotesDueMarch2025InterestEqualTo3.00Member2025-09-300001156375us-gaap:FairValueInputsLevel2Membercme:A750.0MillionFixedRateNotesDueMarch2025InterestEqualTo3.00Member2025-01-012025-09-300001156375us-gaap:FairValueInputsLevel2Membercme:A750MillionFixedRateNotesDueMarch2030InterestEqualTo4.4Domain2025-01-012025-09-300001156375us-gaap:FairValueInputsLevel2Membercme:A750.0millionFixedRateNotesDueSeptember2043InterestEqualTo5.3Member2025-01-012025-09-300001156375us-gaap:FairValueInputsLevel2Membercme:A700.0MillionFixedRateNotesDueJune2048InterestEqualTo4.15MemberDomainDomain2025-01-012025-09-300001156375us-gaap:RestrictedStockMember2025-07-012025-09-300001156375us-gaap:RestrictedStockMember2024-07-012024-09-300001156375us-gaap:RestrictedStockMember2025-01-012025-09-300001156375us-gaap:RestrictedStockMember2024-01-012024-09-30

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_________________________________________________________

FORM 10-Q

_________________________________________________________

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2025

- OR -


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-31553

CME GROUP INC.

(Exact name of registrant as specified in its charter)

Delaware

36-4459170

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)

20 South Wacker Drive

Chicago

Illinois

60606

(Address of principal executive offices)

(Zip Code)

(312) 930-1000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading symbol	Name of each exchange on which registered
Class A Common Stock	CME	The Nasdaq Stock Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

The number of shares outstanding of each of the registrant’s classes of common stock as of October 8, 2025 was as follows: 360,596,647 shares of Class A common stock, $0.01 par value; 625 shares of Class B-1 common stock, $0.01 par value; 813 shares of Class B-2 common stock, $0.01 par value; 1,287 shares of Class B-3 common stock, $0.01 par value; and 413 shares of Class B-4 common stock, $0.01 par value.

Table of Contents

CME GROUP INC.

FORM 10-Q

INDEX



		Page

PART I. FINANCIAL INFORMATION		3

Item 1.	Financial Statements	5

	Consolidated Balance Sheets at September 30, 2025 and December 31, 2024	5

	Consolidated Statements of Income for the Quarters and Nine Months Ended September 30, 2025 and 2024	6

	Consolidated Statements of Comprehensive Income for the Quarters and Nine Months Ended September 30, 2025 and 2024	7

	Consolidated Statements of Equity for the Quarters and Nine Months Ended September 30, 2025 and 2024	8

	Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024	10

	Notes to Unaudited Consolidated Financial Statements	12

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	33

Item 4.	Controls and Procedures	33

PART II. OTHER INFORMATION		33

Item 1.	Legal Proceedings	33

Item 1A.	Risk Factors	33

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	33

Item 5.	Other Information	33

Item 6.	Exhibits	34

SIGNATURES		35

Table of Contents

PART I. FINANCIAL INFORMATION

Certain Terms

All references to “options” or “options contracts” in the text of this document refer to options on futures contracts.

Further information about CME Group and its products can be found at http://www.cmegroup.com. Information made available on our website does not constitute a part of this Quarterly Report on Form 10-Q.

Information about Contract Volume and Average Rate per Contract

All amounts regarding contract volume and average rate per contract are for CME Group’s listed futures and options on futures contracts unless otherwise noted.

Trademark Information

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. (CME), CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group Limited. OSTTRA is a trademark of MarkitSERV Limited. Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P Dow Jones Indices LLC, as the case may be, and have been licensed for use by CME. All other trademarks are the property of their respective owners.

Forward-Looking Statements

From time to time, in this Quarterly Report on Form 10-Q as well as in other written reports and verbal statements, we discuss our expectations regarding future performance. These forward-looking statements are identified by their use of terms and phrases such as “believe,” “anticipate,” “could,” “estimate,” “intend,” “may,” “plan,” “expect” and similar expressions, including references to assumptions. These forward-looking statements are based on currently available competitive, financial and economic data, current expectations, estimates, forecasts and projections about the industries in which we operate and management's beliefs and assumptions. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are:

•increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities;

•our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks;

•our ability to continue introducing innovative and competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and derive revenues that are commensurate with our efforts and expectations, and our ability to maintain the competitiveness of our existing products and services;

•our ability to adjust our fixed costs and expenses if our revenues decline;

•our ability to manage variable costs relating to CME Group's transition to the Google Cloud and minimize duplicative costs during the transition between maintaining the on-premise environment and the Google Cloud environment;

•our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers;

•our ability to expand and globally offer our products and services;

•changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers, as well as the impact of tariffs and tax policy changes and the related uncertainty thereof, restrictions on our ability to offer CME Group products and services in specific geographies or to specific customers or limitations or changes in underlying/physical product flows across geographies;

•the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others;

•decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions;

Table of Contents

•changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure;

•the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing firms and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business;

•the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets;

•our dependence on third-party providers and exposure to risk through third parties, including risks related to the performance, reliability and security of technology used by our third-party providers and third-party providers that our clients and third-parties rely on;

•our reliance on third-party distribution partners, including independent software vendors (ISVs), futures commission merchants (FCMs), introducing brokers, broker-dealers around the world, regulatory reporting and data distributors and platform operators, and other partners, for facilitating trading and for market data information, and potential impacts from changes in their business models and priorities;

•volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including new and existing geopolitical tensions or conflicts, the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers;

•our ability to accommodate increases in contract volume and market data and order transaction traffic across the entire trade cycle and the ability to implement enhancements without failure or degradation of the performance of our trading and clearing systems and meeting our regulatory reporting obligations;

•our ability to execute our growth strategy and maintain our growth effectively;

•our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated with the performance of our joint venture with S&P Dow Jones (S&P Dow Jones Indices LLC) in index services, our primary business and distribution partners’ actions and our partnership with Google, including our ability to manage the successful implementation of our agreements with Google and our data center partners;

•variances in earnings on cash accounts and collateral that our clearing house holds for its clients;

•impact of CME Group pricing/fee level and structure and incentive changes;

•impact of aggregation services and internalization on trade flow and volumes;

•any negative financial impacts from changes to the terms of intellectual property and index rights;

•our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business;

•industry, channel partner and customer consolidation and/or concentration;

•decreases in trading and clearing activity;

•the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions;

•increases in effective tax rates, borrowing costs or changes in tax policy;

•our ability to maintain our brand and reputation; and

•the unfavorable resolution of material legal proceedings.

For a detailed discussion of these and other factors that might affect our performance, see Item 1A. of our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission on February 27, 2025 and Item 1A. in Part II of this Quarterly Report on Form 10-Q.

Table of Contents


ITEM 1.			FINANCIAL STATEMENTS

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(dollars in millions, except par value data; shares in thousands)


	September 30, 2025		December 31, 2024
	(unaudited)
Assets
Current Assets:
Cash and cash equivalents	$	2,446.8	$	2,892.4
Marketable securities	123.2		113.2
Accounts receivable, net of allowance of $9.2 and $9.0	642.9		573.1
Other current assets (includes $6.5 and $6.3 in restricted cash)	546.7		559.4
Performance bonds and guaranty fund contributions	149,041.2		98,895.4
Total current assets	152,800.8		103,033.5
Property, net of accumulated depreciation and amortization of $983.2 and $1,024.3	355.2		386.2
Intangible assets—trading products	17,175.3		17,175.3
Intangible assets—other, net	2,667.8		2,821.6
Goodwill	10,514.5		10,486.9
Other assets	3,631.0		3,543.5
Total Assets	$	187,144.6	$	137,447.0

Liabilities and Equity
Current Liabilities:
Accounts payable	$	74.9	$	79.9
Short-term debt	—		749.8
Other current liabilities	471.1		2,588.8
Performance bonds and guaranty fund contributions	149,041.2		98,895.4
Total current liabilities	149,587.2		102,313.9
Long-term debt	3,421.3		2,678.2
Deferred income tax liabilities, net	5,220.1		5,246.8
Other liabilities	725.7		721.2
Total Liabilities	158,954.3		110,960.1



Shareholders’ Equity:
Preferred stock, $0.01 par value, 10,000 shares authorized as of September 30, 2025 and December 31, 2024; 4,584 issued and outstanding as of September 30, 2025 and December 31, 2024	—		—
Class A common stock, $0.01 par value, 1,000,000 shares authorized at September 30, 2025 and December 31, 2024; 359,849 and 359,602 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	3.6		3.6
Class B common stock, $0.01 par value, 3 shares authorized, issued and outstanding as of September 30, 2025 and December 31, 2024	—		—
Additional paid-in capital	22,436.9		22,403.0
Retained earnings	5,706.4		4,185.8
Accumulated other comprehensive income (loss)	43.4		(105.5)
Total CME Group Shareholders’ Equity	28,190.3		26,486.9


Total Liabilities and Equity	$	187,144.6	$	137,447.0

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(dollars in millions, except per share data; shares in thousands)

(unaudited)


	Quarter Ended				Nine Months Ended
	September 30,				September 30,
	2025		2024		2025		2024
Revenues
Clearing and transaction fees	$	1,227.9	$	1,297.1	$	3,953.2	$	3,755.9
Market data and information services	202.5		178.2		595.1		528.6
Other	107.2		109.1		323.6		320.3
Total Revenues	1,537.6		1,584.4		4,871.9		4,604.8
Expenses
Compensation and benefits	237.6		218.8		665.9		629.5
Technology	71.4		66.6		208.0		190.1
Professional fees and outside services	36.7		31.0		102.6		98.8
Amortization of purchased intangibles	56.2		55.7		167.5		166.4
Depreciation and amortization	26.4		28.2		81.0		87.0
Licensing and other fee agreements	81.6		97.6		274.4		271.4
Other	55.1		62.3		162.6		177.2
Total Expenses	565.0		560.2		1,662.0		1,620.4
Operating Income	972.6		1,024.2		3,209.9		2,984.4

Non-Operating Income (Expense)
Investment income	1,548.7		1,026.8		3,959.8		3,142.6
Interest and other borrowing costs	(44.0)		(40.2)		(129.7)		(120.2)
Equity in net earnings of unconsolidated subsidiaries	96.3		86.1		283.5		259.7
Other non-operating income (expense)	(1,396.6)		(920.0)		(3,571.4)		(2,821.7)
Total Non-Operating Income (Expense)	204.4		152.7		542.2		460.4
Income before Income Taxes	1,177.0		1,176.9		3,752.1		3,444.8
Income tax provision	269.0		264.1		862.8		793.6


Net Income	$	908.0	$	912.8	$	2,889.3	$	2,651.2
Net Income Attributable to Common Shareholders of CME Group	$	896.6	$	901.3	$	2,853.0	$	2,617.8

Earnings per Share Attributable to Common Shareholders of CME Group:
Basic	$	2.49	$	2.51	$	7.93	$	7.29
Diluted	2.49		2.50		7.92		7.27
Weighted Average Number of Common Shares:
Basic	359,686		359,400		359,653		359,329
Diluted	360,422		359,989		360,330		359,899

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in millions)

(unaudited)


	Quarter Ended				Nine Months Ended
	September 30,				September 30,
	2025		2024		2025		2024
Net income	$	908.0	$	912.8	$	2,889.3	$	2,651.2
Other comprehensive income (loss), net of tax:
Investment securities:
Net unrealized holding gains (losses) arising during the period	0.2		0.6		0.3		0.6

Income tax benefit (expense)	(0.1)		(0.2)		(0.1)		(0.2)
Investment securities, net	0.1		0.4		0.2		0.4
Defined benefit plans:
Net change in defined benefit plans arising during the period	—		—		(1.2)		(5.9)
Amortization of net actuarial (gains) losses included in compensation and benefits expense	(0.1)		0.1		(0.2)		0.1
Income tax benefit (expense)	—		—		0.3		1.5
Defined benefit plans, net	(0.1)		0.1		(1.1)		(4.3)
Derivative investments:


Reclassification of net unrealized (gains) losses to interest expense and other non-operating income (expense)	(1.1)		(0.9)		(3.1)		(2.7)
Income tax benefit (expense)	0.4		0.3		0.9		0.7
Derivative investments, net	(0.7)		(0.6)		(2.2)		(2.0)
Foreign currency translation:
Foreign currency translation adjustments	(1.9)		88.4		162.4		54.8

Income tax benefit (expense)	0.6		(4.2)		(10.4)		(4.2)
Foreign currency translation, net	(1.3)		84.2		152.0		50.6
Other comprehensive income (loss), net of tax	(2.0)		84.1		148.9		44.7
Comprehensive income	$	906.0	$	996.9	$	3,038.2	$	2,695.9

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EQUITY

(dollars in millions, except per share data; shares in thousands)

(unaudited)


	Nine Months Ended, September 30, 2025
	Preferred Stock (Shares)	Class A Common Stock (Shares)	Class B Common Stock (Shares)	Preferred Stock, Common Stock and Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total CME Group Shareholders’ Equity
Balance at December 31, 2024	4,584	359,602	3	$	22,406.6	$	4,185.8	$	(105.5)	$	26,486.9
Net income						2,889.3				2,889.3
Other comprehensive income (loss)								148.9		148.9
Dividends on common and preferred stock of $3.75 per share						(1,368.7)				(1,368.7)




Vesting of issued restricted Class A common stock		252		(31.0)						(31.0)
Shares issued to Board of Directors		11		3.0						3.0
Shares issued under Employee Stock Purchase Plan		16		4.2						4.2
Repurchase of Class A common stock (1)		(32)		(8.2)						(8.2)
Stock-based compensation				65.9						65.9
Balance at September 30, 2025	4,584	359,849	3	$	22,440.5	$	5,706.4	$	43.4	$	28,190.3


	Quarter Ended, September 30, 2025
	Preferred Stock (Shares)	Class A Common Stock (Shares)	Class B Common Stock (Shares)	Preferred Stock, Common Stock and Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total CME Group Shareholders’ Equity
Balance at June 30, 2025	4,584	359,647	3	$	22,438.7	$	5,254.9	$	45.4	$	27,739.0
Net income						908.0				908.0
Other comprehensive income (loss)								(2.0)		(2.0)
Dividends on common and preferred stock of $1.25 per share						(456.5)				(456.5)




Vesting of issued restricted Class A common stock		202		(22.2)						(22.2)



Stock-based compensation				24.0						24.0
Balance at September 30, 2025	4,584	359,849	3	$	22,440.5	$	5,706.4	$	43.4	$	28,190.3

(1) In December 2024, the board of directors approved a share repurchase program (the Share Repurchase Program), which authorizes the repurchase of up to $3.0 billion of CME Group Class A common stock at prevailing market prices. During the three and nine months ended September 30, 2025, 0 and 32,265 shares of outstanding Class A common stock were repurchased, respectively. The average price was $253.05 per share for a total of $8.2 million. The remaining aggregate amount under the existing Share Repurchase Program is $2,991.8 million. Shares are retired upon repurchase and not held as treasury stock.

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EQUITY

(dollars in millions, except per share data; shares in thousands)

(unaudited)


	Nine Months Ended, September 30, 2024
	Preferred Stock (Shares)	Class A Common Stock (Shares)	Class B Common Stock (Shares)	Preferred Stock, Common Stock and Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total CME Group Shareholders’ Equity
Balance at December 31, 2023	4,584	359,231	3	$	22,338.3	$	4,455.2	$	(55.6)	$	26,737.9
Net income						2,651.2				2,651.2
Other comprehensive income (loss)								44.7		44.7
Dividends on common stock and preferred stock of $3.45 per share						(1,258.2)				(1,258.2)




Vesting of issued restricted Class A common stock		289		(29.5)						(29.5)
Shares issued to Board of Directors		19		3.7						3.7
Shares issued under Employee Stock Purchase Plan		20		4.0						4.0
Stock-based compensation				62.4						62.4
Balance at September 30, 2024	4,584	359,559	3	$	22,378.9	$	5,848.2	$	(10.9)	$	28,216.2


	Quarter Ended, September 30, 2024
	Preferred Stock (Shares)	Class A Common Stock (Shares)	Class B Common Stock (Shares)	Preferred Stock, Common Stock and Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total CME Group Shareholders’ Equity
Balance at June 30, 2024	4,584	359,361	3	$	22,375.7	$	5,355.1	$	(95.0)	$	27,635.8
Net income						912.8				912.8
Other comprehensive income (loss)								84.1		84.1
Dividends on common stock and preferred stock of $1.15 per share						(419.7)				(419.7)



Vesting of issued restricted Class A common stock		198		(17.1)						(17.1)


Stock-based compensation				20.3						20.3
Balance at September 30, 2024	4,584	359,559	3	$	22,378.9	$	5,848.2	$	(10.9)	$	28,216.2

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(unaudited)


	Nine Months Ended September 30,
	2025		2024
Cash Flows from Operating Activities
Net income	$	2,889.3	$	2,651.2
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	65.9		62.4
Amortization of purchased intangibles	167.5		166.4
Depreciation and amortization	81.0		87.0

Net realized and unrealized (gains) losses on investments	(3.0)		(11.7)

Deferred income taxes	(27.4)		(21.9)
Change in:
Accounts receivable	(69.9)		(95.2)
Other current assets	(21.9)		598.7
Other assets	81.4		38.1
Accounts payable	(5.0)		39.3
Income taxes payable	27.6		(128.0)
Other current liabilities	(9.3)		(691.4)
Other liabilities	(7.6)		(17.0)
Other	(25.4)		(5.3)
Net Cash Provided by Operating Activities	3,143.2		2,672.6

Cash Flows from Investing Activities
Proceeds from maturities of available-for-sale marketable securities	6.2		4.9
Purchases of available-for-sale marketable securities	(4.9)		(4.3)
Purchases of property, net	(51.0)		(67.8)


Investments in privately-held equity investments	(3.4)		(3.6)

Proceeds from sales of investments	—		13.5
Net Cash Used in Investing Activities	(53.1)		(57.3)

Cash Flows from Financing Activities

Proceeds from debt, net of issuance costs	740.6		—
Repayment of debt	(750.0)		—
Cash dividends	(3,478.0)		(3,165.4)

Repurchase of Class A common stock, including costs	(8.2)		—
Change in performance bond and guaranty fund contributions	50,145.7		9,264.5
Employee taxes paid on restricted stock vesting	(31.0)		(29.5)
Other	(8.8)		(9.0)
Net Cash Provided by Financing Activities	46,610.3		6,060.6

Table of Contents

CME GROUP INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

(in millions)

(unaudited)


	Nine Months Ended September 30,
	2025		2024
Net change in cash, cash equivalents, restricted cash and restricted cash equivalents	$	49,700.4	$	8,675.9
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period	101,794.1		93,109.7
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, End of Period	$	151,494.5	$	101,785.6

Reconciliation of cash, cash equivalents, restricted cash and restricted cash equivalents:
Cash and cash equivalents	$	2,446.8	$	2,322.1
Short-term restricted cash	6.5		6.5

Restricted cash and restricted cash equivalents (performance bonds and guaranty fund contributions)	149,041.2		99,457.0
Total	$	151,494.5	$	101,785.6

Supplemental Disclosure of Cash Flow Information
Income taxes paid	$	855.2	$	938.6
Interest paid	111.7		106.0

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Basis of Presentation

The consolidated financial statements consist of CME Group Inc. (CME Group) and its subsidiaries (collectively, the company), including Chicago Mercantile Exchange Inc. (CME), Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX), Commodity Exchange, Inc. (COMEX) and NEX Group Limited (NEX). The clearing house is operated by CME.

The accompanying interim consolidated financial statements have been prepared by CME Group without audit. Certain notes and other information normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted. In the opinion of management, the accompanying consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) considered necessary to present fairly the financial position of the company at September 30, 2025 and December 31, 2024 and the results of operations and cash flows for the periods indicated. Quarterly results are not necessarily indicative of results for any subsequent period.

The accompanying consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto in CME Group’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission (SEC) on February 27, 2025.

2. Accounting Policies

Recent Accounting Pronouncements. The following accounting pronouncements were issued during 2025:

In July 2025, the FASB issued an accounting standards update which provides a practical expedient when estimating the amount of expected credit losses on current accounts receivable and current contract assets. This update permits entities to assume that current conditions as of the balance sheet date do not change for the remaining life of the current accounts receivable and current contract assets. Therefore, entities will not need to develop reasonable and supportable forecasts of future economic conditions. The practical expedient must be applied consistently across all current accounts receivable and current contract assets. This guidance is effective beginning in 2026, on an interim and annual basis, and must be adopted prospectively. Upon adoption, entities are required to disclose whether they have applied the practical expedient. Early adoption is permitted. Adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

In September 2025, the FASB issued an accounting standards update that clarifies and modernizes the accounting for costs related to internal-use software. The guidance removes all references to project stages and clarifies the threshold entities apply to begin capitalizing costs. With the removal of all references to project stages, the new guidance requires entities to begin capitalizing software costs when both of the following occur: (a) Management, with the relevant authority, implicitly or explicitly authorizes and commits to funding a computer software project and (b) It is probable that the project will be completed and the software will be used to perform the function intended. The guidance specifies that the property, plant, and equipment disclosure requirements apply to capitalized software costs, regardless of how those costs are presented in the financial statements. The guidance is effective beginning in 2028, on an interim and annual basis. Entities may apply the guidance using a prospective, retrospective, or modified transition approach. Early adoption is permitted. Adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

3. Revenue Recognition

The company generates revenue from customers from the following sources:

Clearing and transaction fees. Clearing and transaction fees include per-contract charges for trade matching, clearing, trading on the company's electronic trading platforms, portfolio reconciliation and compression services, risk mitigation, and other fees. Clearing and transaction fees are assessed upfront at the time of trade execution. As such, the company recognizes the majority of the fee revenue upon successful execution of the trade. The minimal remaining portion of the fee revenue related to settlement activities performed after trade execution is recognized over the short-term period that the contract is outstanding, based on management’s estimates of the average contract lifecycle. These estimates are based on various assumptions to approximate the amount of fee revenue to be attributed to services performed through contract settlement, expiration, or termination. For cleared trades, these assumptions include the average number of days that a contract remains in open interest, contract turnover, average revenue per day, and the number of contracts remaining in open interest at the end of each period.

The nature of contracts gives rise to several types of variable consideration, including volume-based pricing tiers, customer incentives associated with market maker programs and other fee discounts. The company includes fee discounts and incentives in the estimated transaction price when there is a basis to reasonably estimate the amount of the fee reduction. These estimates are based on historical experience, anticipated performance, and best judgment at the time. Because of the company's certainty in estimating these amounts, they are included in the transaction price of contracts.

Table of Contents

Market data and information services. Market data and information services represent revenue from the dissemination of market data to subscribers, distributors, and other third-party licensees of market data. Pricing for market data is primarily based on the number of reportable devices used as well as the number of subscribers enrolled under the arrangement. Fees for these services are generally billed monthly. Market data services are satisfied over time and revenue is recognized on a monthly basis as the customers receive and consume the benefit of the market data services. However, the company also maintains certain annual license arrangements with one-time upfront fees. The fees for annual licenses are initially recorded as a contract liability and recognized as revenue monthly over the term of the annual period.

Other. Other revenues include certain access and communication fees, fees for collateral management, equity membership subscription fees, and fees for trade order routing through agreements from various strategic relationships. Access and communication fees are charged to customers that utilize various telecommunications networks and communications services. Fees for these services are generally billed monthly and the associated fee revenue is recognized as billed. Collateral management fees are charged to clearing firms that have collateral on deposit with the clearing house to meet their minimum performance bond and guaranty fund obligations on the exchange. These fees are calculated based on daily collateral balances and are billed monthly. This fee revenue is recognized monthly as billed as the customers receive and consume the benefits of the services. The company also has an equity membership program which provides equity members the option to pay a monthly subscription fee in satisfaction of their existing requirement to hold CME Group Class A common stock. Choosing to pay this fee in lieu of holding Class A shares is entirely voluntary and the client's choice. Fee revenue under this program is earned monthly as billed over the contractual term. Pricing for strategic relationships may be driven by customer levels and activity. There are fee arrangements which provide for monthly as well as quarterly payments in arrears. Revenue is recognized monthly for strategic relationship arrangements as the customers receive and consume the benefits of the services.

The following table represents a disaggregation of revenue from contracts with customers by product line for the quarters and nine months ended September 30, 2025 and 2024:


	Quarter Ended September 30,				Nine Months Ended September 30,
(in millions)	2025		2024		2025		2024
Interest rates	$	417.2	$	445.8	$	1,315.0	$	1,249.1
Equity indexes	261.9		291.8		867.7		828.1
Foreign exchange	44.9		51.9		150.7		150.2
Agricultural commodities	155.9		139.1		495.0		432.5
Energy	178.3		204.9		612.1		601.0
Metals	79.4		71.8		235.4		218.4
BrokerTec fixed income	39.3		33.3		112.2		108.9
EBS foreign exchange	30.5		35.2		103.2		99.0
Interest rate swap	20.5		23.3		61.9		68.7
Total clearing and transaction fees	1,227.9		1,297.1		3,953.2		3,755.9
Market data and information services	202.5		178.2		595.1		528.6
Other	107.2		109.1		323.6		320.3
Total revenues	$	1,537.6	$	1,584.4	$	4,871.9	$	4,604.8

Timing of Revenue Recognition
Services transferred at a point in time	$	1,201.1	$	1,270.0	$	3,871.9	$	3,677.5
Services transferred over time	331.3		309.5		984.2		912.2
One-time charges and miscellaneous revenues	5.2		4.9		15.8		15.1
Total revenues	$	1,537.6	$	1,584.4	$	4,871.9	$	4,604.8

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, and customer advances and deposits (contract liabilities) on the consolidated balance sheets. Certain fees for transactions, annual licenses, and other revenue arrangements are billed upfront before revenue is recognized, which results in the recognition of contract liabilities. These liabilities are recognized on the consolidated balance sheets on a contract-by-contract basis upon commencement of services under the customer contract. These upfront customer payments are recognized as revenue over time as the obligations under the contracts are satisfied. Changes in the contract liability balances during the third quarter of 2025 were not materially impacted by any other factors. The balance of contract liabilities was $31.3 million and $15.6 million as of September 30, 2025 and December 31, 2024, respectively.

Table of Contents

4. Performance Bonds and Guaranty Fund Contributions

Performance Bonds and Guaranty Fund Contribution Reinvestment. CME reinvests cash performance bonds and guaranty fund contributions and distributes a portion of the interest earned back to the clearing firms. The reinvestment of cash can include certain commercial and central bank deposits, government securities, reverse repurchase agreements, and money market funds. CME has been designated as a systemically important financial market utility by the Financial Stability Oversight Council and is authorized to maintain cash accounts at the Federal Reserve Bank of Chicago. At September 30, 2025, CME maintained $138.4 billion within the cash account at the Federal Reserve Bank of Chicago. The cash deposit at the Federal Reserve Bank of Chicago is included within performance bonds and guaranty fund contributions on the consolidated balance sheets. Cash performance bonds and guaranty fund contributions are included as restricted cash and restricted cash equivalents on the consolidated statements of cash flows.

In the third quarter and first nine months of 2025, earnings from cash performance bond and guaranty fund contributions were $1,514.1 million and $3,875.3 million, respectively, compared with $991.3 million and $3,035.6 million in the third quarter and first nine months of 2024, respectively. In the third quarter and first nine months of 2025, expenses related to the distribution of interest earned on collateral reinvestments were $1,399.2 million and $3,578.5 million, respectively, compared with $922.6 million and $2,829.4 million in the third quarter and first nine months of 2024, respectively. The earnings from cash performance bonds and guaranty fund contributions are included in investment income and the expense related to the distribution of interest earned is included in other non-operating income (expense) on the consolidated statements of income.

Clearing House Contract Settlement. The clearing house marks-to-market open positions at least once a day (twice a day for all futures and options contracts). Based on values derived from the mark-to-market process, the clearing house requires payments from clearing firms whose positions have lost value and makes payments to clearing firms whose positions have gained value. Under the extremely unlikely scenario of simultaneous default by every clearing firm who has open positions with unrealized losses, the maximum exposure related to positions other than cleared-only interest rate swap contracts would be one half day of changes in fair value of all open positions, before considering the clearing house’s ability to access defaulting clearing firms' collateral deposits.

For cleared interest rate swap contracts, the maximum exposure at the time of default related to the clearing house’s guarantee would be one full day of changes in fair value of all open positions, before considering the clearing house’s ability to access defaulting clearing firms' collateral deposits.

During the first nine months of 2025, the clearing house transferred an average of approximately $6.7 billion a day through its clearing systems for settlement from clearing firms whose positions had lost value to clearing firms whose positions had gained value. The clearing house reduces its guarantee exposure through initial and maintenance performance bond requirements and mandatory guaranty fund contributions. Management has assessed the fair value of the company’s settlement guarantee liability by taking the following factors into consideration: the design and operations of the clearing risk management process, the financial safeguard packages in place, historical evidence of default by a clearing firm and the estimated probability of potential payouts by the clearing house. Based on the assessment performed, management estimates the guarantee liability to be nominal and therefore has not recorded any liability at September 30, 2025 and December 31, 2024. The company does not have a history of significant losses recognized on performance bond collateral as posted by our clearing firms, and management currently does not anticipate any future credit losses on its performance bond assets. Accordingly, the company has not provided an allowance for credit losses on these performance bond deposits, nor has it recorded any liabilities to reflect an allowance for credit losses related to our off-balance sheet credit exposures and guarantees.

Table of Contents

5. Intangible Assets and Goodwill

Intangible assets consisted of the following at September 30, 2025 and December 31, 2024:


	September 30, 2025				December 31, 2024
(in millions)	Assigned Value		Accumulated Amortization		Net Book Value		Assigned Value		Accumulated Amortization		Net Book Value
Amortizable Intangible Assets:
Clearing firm, market data and other customer relationships	$	4,705.0	$	(2,504.5)	$	2,200.5	$	4,683.5	$	(2,334.4)	$	2,349.1

Technology-related intellectual property	62.5		(62.5)		—		62.5		(62.5)		—
Other	73.8		(56.5)		17.3		71.1		(48.6)		22.5
Total amortizable intangible assets	$	4,841.3	$	(2,623.5)	$	2,217.8	$	4,817.1	$	(2,445.5)	$	2,371.6

Indefinite-Lived Intangible Assets:
Trade names					450.0						450.0
Total intangible assets – other, net					$	2,667.8					$	2,821.6
Trading products (1)					$	17,175.3					$	17,175.3

(1)Trading products represent futures and options products acquired in our business combinations with CBOT Holdings, Inc., NYMEX Holdings, Inc. and The Board of Trade of Kansas City, Missouri, Inc. Clearing and transaction fees are generated through the trading of these products. These trading products, most of which have traded for decades, require authorization from the Commodity Futures Trading Commission (CFTC). Product authorizations from the CFTC have no term limits.

Total amortization expense for intangible assets was $56.2 million and $55.7 million for the quarters ended September 30, 2025 and 2024, respectively. Total amortization expense for intangible assets was $167.5 million and $166.4 million for the nine months ended September 30, 2025 and 2024, respectively. During the nine months ended September 30, 2025, the net book value of amortizable intangible assets included $13.6 million of foreign currency translation for the period.

As of September 30, 2025, the future estimated amortization expense related to amortizable intangible assets is expected to be as follows:


(in millions)	Amortization Expense
Remainder of 2025	$	55.8
2026	223.1
2027	221.8
2028	215.1
2029	215.1
2030	215.1
Thereafter	1,071.8

Goodwill activity consisted of the following for the periods ended September 30, 2025 and December 31, 2024:


(in millions)	Goodwill
Balance at December 31, 2023	$	10,495.3
Foreign currency translation	(8.4)
Balance at December 31, 2024	10,486.9
Foreign currency translation	27.6
Balance at September 30, 2025	$	10,514.5

Table of Contents

6. Debt

Short-term debt consisted of the following at September 30, 2025 and December 31, 2024:


(in millions)	September 30, 2025		December 31, 2024
$750.0 million fixed rate notes due March 2025, stated rate of 3.00% (1)	$	—	$	749.8
Total short-term debt	$	—	$	749.8

(1)The company maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 3.11%.

Long-term debt consisted of the following at September 30, 2025 and December 31, 2024:


(in millions)	September 30, 2025		December 31, 2024
$500.0 million fixed rate notes due June 2028, stated rate of 3.75%	$	498.8	$	498.5
$750.0 million fixed rate notes due March 2030, stated rate of 4.40%	741.6		—
$750.0 million fixed rate notes due March 2032, stated rate of 2.65%	744.4		743.7
$750.0 million fixed rate notes due September 2043, stated rate of 5.30% (1)	744.5		744.3
$700.0 million fixed rate notes due June 2048, stated rate of 4.15%	692.0		691.7
Total long-term debt	$	3,421.3	$	2,678.2

Long-term debt maturities, at par value, were as follows at September 30, 2025:


(in millions)	Par Value
2026	$	—
2027	—
2028	500.0
2029	—
2030	750.0
Thereafter	2,200.0

7. Contingencies

Legal and Regulatory Matters. In the normal course of business, the company discusses matters with its regulators raised during regulatory examinations or otherwise subject to their inquiry and oversight. These matters could result in censures, fines, penalties or other sanctions. Management believes the outcome of any resulting actions will not have a material impact on the company's consolidated financial position or results of operations. However, the company is unable to predict the outcome or the timing of the ultimate resolution of these matters, or the potential fines, penalties or injunctive or other equitable relief, if any, that may result from these matters.

A putative class action complaint was filed January 15, 2014 in the Circuit Court of Cook County, Chancery Division, against CME Group Inc. and the Board of Trade of the City of Chicago, Inc. The plaintiffs, certain Class B shareholders of CME Group and Class B members of CBOT, allege breach of contract and breach of the implied covenant of good faith and fair dealing for violations of their core rights granted in the defendants’ respective Certificates of Incorporation. On December 2, 2021, the court granted the plaintiffs’ motion for certification of a damages-only class. In early 2024, the defendants moved for summary judgment on all claims. On April 16, 2025, the court granted the motion in part and denied the motion in part, and set the remaining claims for a jury trial. After a three week trial, on July 25, 2025, the jury returned a unanimous verdict in favor of the defendants on all counts. Plaintiffs have filed a post-trial motion seeking a new trial, and we expect the plaintiffs to appeal the verdict should the post-trial motions be denied.

In addition, the company is a defendant in, and has potential for, various other legal proceedings arising from its regular business activities. While the ultimate results of such proceedings against the company cannot be predicted with certainty, the company believes that the resolution of any of these matters on an individual or aggregate basis will not have a material impact on its consolidated financial position or results of operations. No accrual was required for contingent legal and regulatory matters as none were probable and estimable as of September 30, 2025 and December 31, 2024.

Intellectual Property Indemnifications. Certain agreements with customers and other third parties related to accessing the CME Group platforms, utilizing market data services and licensing CME SPAN and SPAN 2 software may contain indemnifications from intellectual property claims that may be made against them as a result of their use of the applicable products and/or

Table of Contents

services. The potential future claims relating to these indemnifications cannot be estimated and therefore no liability has been recorded.

8. Leases

The company has operating leases for corporate offices. The operating leases have remaining lease terms of up to 13 years, some of which include options to extend or renew the leases for up to an additional five years, and some of which include options to early terminate the leases in less than 12 months. Management evaluates whether these options are exercisable at least quarterly in order to determine whether the contract term must be reassessed. For a small number of the leases, primarily the international locations, management’s approach is to enter into short-term leases for a lease term of 12 months or less in order to provide for greater flexibility in the local environment. For certain office spaces, the company has entered into arrangements to sublease excess space to third parties, while the original lease contract remains in effect with the landlord.

The company also has one finance lease, which is related to the sale of our data center in March 2016. In connection with the sale, the company leased back a portion of the property. The transaction was recognized under the financing method and not as a sale leaseback arrangement.

The right-of-use lease asset is recorded within other assets, and the present value of the lease liability is recorded within other liabilities (segregated between short term and long term) on the consolidated balance sheets. The discount rate applied to the lease payments represents the company’s incremental borrowing rate.

The components of lease costs were as follows:


	Quarter Ended September 30,				Nine Months Ended September 30,
(in millions)	2025		2024		2025		2024
Operating lease expense:
Operating lease cost	$	12.6	$	12.7	$	26.4	$	38.9
Short-term lease cost	0.1		0.1		0.3		0.3
Total operating lease expense included in other expense	$	12.7	$	12.8	$	26.7	$	39.2

Finance lease expense:
Interest expense	$	0.5	$	0.5	$	1.5	$	1.7
Depreciation expense	2.2		2.2		6.5		6.5
Total finance lease expense	$	2.7	$	2.7	$	8.0	$	8.2

Sublease revenue included in other revenue	$	3.2	$	2.5	$	9.4	$	7.2

Supplemental cash flow information related to leases was as follows:


	Quarter Ended September 30,				Nine Months Ended September 30,
(in millions)	2025		2024		2025		2024
Cash outflows for operating leases	$	14.5	$	15.4	$	44.8	$	45.9
Cash outflows for finance leases	4.4		4.3		13.1		13.0

Table of Contents

Supplemental balance sheet information related to leases was as follows:

Operating leases


(in millions)	September 30, 2025			December 31, 2024
Operating lease right-of-use assets	$	219.9		$	231.1

Operating lease liabilities:
Other current liabilities	$	46.3		$	44.7
Other liabilities	249.0			289.3
Total operating lease liabilities	$	295.3		$	334.0



Weighted average remaining lease term (in months)	101			106
Weighted average discount rate	4.1		%	4.2		%

Finance leases


(in millions)	September 30, 2025			December 31, 2024
Finance lease right-of-use assets	$	47.7		$	54.2

Finance lease liabilities:
Other current liabilities	$	8.9		$	8.7
Other liabilities	44.0			50.7
Total finance lease liabilities	$	52.9		$	59.4

Weighted average remaining lease term (in months)	66			75
Weighted average discount rate	3.5		%	3.5		%

Future minimum lease payments were as follows as of September 30, 2025 for operating and finance leases:


(in millions)	Operating Leases
Remainder of 2025	$	14.4
2026	57.1
2027	49.7
2028	44.0
2029	33.3
2030	32.3
Thereafter	111.3
Total lease payments	342.1
Less: imputed interest	(46.8)
Present value of lease liability	$	295.3

Table of Contents


(in millions)	Finance Leases
Remainder of 2025	$	4.4
2026	17.6
2027	17.8
2028	17.9
2029	18.1
2030	18.3
Thereafter	4.6
Total lease payments	98.7
Less: imputed interest	(45.8)
Present value of lease liability	$	52.9

9. Guarantees

Mutual Offset Agreement. CME and Singapore Exchange Limited (SGX) maintain a mutual offset agreement with a current term through April 2027. This agreement enables market participants to open a futures position on one exchange and liquidate it on the other. The term of the agreement will automatically renew for a two-year period after April 2027 unless either party provides advance notice of their intent to terminate. CME can maintain collateral in the form of irrevocable, standby letters of credit. At September 30, 2025, CME was contingently liable to SGX on letters of credit totaling $400.0 million. CME also maintains a $350.0 million line of credit to meet its obligations under this agreement. Regardless of the collateral, CME guarantees all cleared transactions submitted through SGX and would initiate procedures designed to satisfy these financial obligations in the event of a default, such as the use of performance bonds and guaranty fund contributions of the defaulting clearing firm. Management has assessed the fair value of the company’s guarantee liability under this mutual offset agreement by taking the following factors into consideration: the design and operations of the clearing risk management process, the financial safeguard packages in place, historical evidence of default by a clearing member and the estimated probability of potential payouts by the clearing house. Based on the assessment performed, management estimates the guarantee liability to be nominal and therefore has not recorded any liability at September 30, 2025 and December 31, 2024.

Family Farmer and Rancher Protection Fund. In 2012, the company established the Family Farmer and Rancher Protection Fund (the Fund). The Fund is designed to provide payments, up to certain maximum levels, to family farmers, ranchers and other agricultural industry participants who use the company’s agricultural commodity products and who suffer losses to their segregated account balances due to their CME clearing member becoming insolvent. Under the terms of the Fund, farmers and ranchers are eligible for up to $25,000 per participant. Farming and ranching cooperatives are eligible for up to $100,000 per cooperative. The Fund was established with a maximum of $100.0 million available for distribution to participants. Since its establishment, the Fund has made payments of approximately $2.0 million, which leaves $98.0 million available for future claims. If, at any time, payments due to participants were to exceed the amount remaining in the Fund, payments would be pro-rated. Clearing members and customers must register with the company in advance and provide certain documentation in order to substantiate their eligibility. The company believes that its guarantee liability is nominal and therefore has not recorded any liability at September 30, 2025 and December 31, 2024.

Table of Contents

10. Accumulated Other Comprehensive Income (Loss)

The following tables present changes in the accumulated balances for each component of other comprehensive income (loss), including current period other comprehensive income (loss) and reclassifications out of accumulated other comprehensive income (loss):


(in millions)	Investment Securities		Defined Benefit Plans		Derivative Investments		Foreign Currency Translation		Total
Balance at December 31, 2024	$	(0.3)	$	(14.1)	$	59.3	$	(150.4)	$	(105.5)
Other comprehensive income (loss) before reclassifications and income tax benefit (expense)	0.3		(1.2)		—		162.4		161.5
Amounts reclassified from accumulated other comprehensive income (loss)	—		(0.2)		(3.1)		—		(3.3)
Income tax benefit (expense)	(0.1)		0.3		0.9		(10.4)		(9.3)
Net current period other comprehensive income (loss)	0.2		(1.1)		(2.2)		152.0		148.9
Balance at September 30, 2025	$	(0.1)	$	(15.2)	$	57.1	$	1.6	$	43.4


(in millions)	Investment Securities		Defined Benefit Plans		Derivative Investments		Foreign Currency Translation		Total
Balance at December 31, 2023	$	(0.4)	$	(23.4)	$	62.0	$	(93.8)	$	(55.6)
Other comprehensive income (loss) before reclassifications and income tax benefit (expense)	0.6		(5.9)		—		54.8		49.5

Amounts reclassified from accumulated other comprehensive income (loss)	—		0.1		(2.7)		—		(2.6)
Income tax benefit (expense)	(0.2)		1.5		0.7		(4.2)		(2.2)
Net current period other comprehensive income (loss)	0.4		(4.3)		(2.0)		50.6		44.7

Balance at September 30, 2024	$	—	$	(27.7)	$	60.0	$	(43.2)	$	(10.9)

11. Fair Value Measurements

The company uses a three-level classification hierarchy of fair value measurements for disclosure purposes:

•Level 1 inputs, which are considered the most reliable evidence of fair value, consist of quoted prices (unadjusted) for identical assets or liabilities in active markets.

•Level 2 inputs consist of observable market data, such as quoted prices for similar assets and liabilities in active markets, or inputs other than quoted prices that are directly observable.

•Level 3 inputs consist of unobservable inputs which are derived and cannot be corroborated by market data or other entity-specific inputs.

The company’s level 1 assets generally include investments in publicly traded mutual funds, equity securities and corporate debt securities with quoted market prices. In general, the company uses quoted prices in active markets for identical assets to determine the fair value of marketable securities.

The company’s level 2 assets and liabilities generally consist of long-term debt notes. The fair values of the long-term debt notes were based on quoted market prices in an inactive market.

The company’s level 3 assets and liabilities include certain investments that were adjusted to fair value.

Table of Contents

Recurring Fair Value Measurements. Financial assets and liabilities recorded at fair value on the consolidated balance sheet as of September 30, 2025 were classified in their entirety based on the lowest level of input that was significant to each asset and liability’s fair value measurement. The following table presents financial instruments measured at fair value on a recurring basis:


	September 30, 2025
(in millions)	Level 1		Level 2		Level 3		Total
Assets at Fair Value:
Marketable securities:
Corporate debt securities	$	7.7	$	—	$	—	$	7.7

Mutual funds	115.3		—		—		115.3
Equity securities	0.2		—		—		0.2

Total Marketable Securities	123.2		—		—		123.2





Total Assets at Fair Value	$	123.2	$	—	$	—	$	123.2

Non-Recurring Fair Value Measurements. The company recognized an unrealized gain on investments of $1.4 million on an equity investment without readily determinable fair value during the first nine months of 2025. The fair value of this investment was estimated to be $10.2 million at September 30, 2025. This fair value assessment was based on quantitative factors, including observable price changes. The fair value measurement of this investment is considered level 3 and non-recurring. This investment is included in other assets on the consolidated balance sheet.

Fair Values of Debt Notes. The following presents the estimated fair values of short-term and long-term debt notes, which are carried at amortized cost on the consolidated balance sheets. The fair values below are classified as level 2 under the fair value hierarchy and were estimated using quoted market prices in inactive markets.

At September 30, 2025, the fair values were as follows:


(in millions)	Fair Value		Level

$500.0 million fixed rate notes due June 2028	$	498.9	Level 2
$750.0 million fixed rate notes due March 2030	759.3		Level 2
$750.0 million fixed rate notes due March 2032	682.1		Level 2
$750.0 million fixed rate notes due September 2043	767.6		Level 2
$700.0 million fixed rate notes due June 2048	596.9		Level 2

Table of Contents

12. Earnings Per Share

The company uses the two-class method to calculate basic and diluted earnings per common share because the shares of its Series G preferred stock are participating securities. Under the two-class method, undistributed earnings are allocated to common stock and participating securities according to their respective rights in undistributed earnings, as if all of the earnings for the period had been distributed. Basic earnings per common share is computed by dividing the net income attributable to common shareholders by the weighted average number of common shares outstanding during the period. Net income attributable to common shareholders is reduced for preferred stock dividends earned during the period. Preferred stock also receives a proportionate allocation of undistributed or overdistributed earnings for the period because the shares of its Series G preferred stock have a contractual obligation to share in profits and losses of the company. Diluted earnings per share is computed by dividing the net income attributable to common shareholders by the weighted average number of common shares outstanding plus potentially dilutive common shares. Anti-dilutive stock awards were as follows for the periods presented:


	Quarter Ended September 30,		Nine Months Ended September 30,
(in thousands)	2025	2024	2025	2024

Stock awards	—	333	79	334
Total	—	333	79	334

The following table presents the earnings per share calculation for the periods presented:


	Quarter Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Net Income (in millions)	$	908.0	$	912.8	$	2,889.3	$	2,651.2
Less: preferred stock dividends	(5.7)		(5.3)		(17.2)		(15.8)
Less: undistributed earnings allocated to preferred stock	(5.7)		(6.2)		(19.1)		(17.6)
Net Income Attributable to Common Shareholders of CME Group	$	896.6	$	901.3	$	2,853.0	$	2,617.8

Weighted Average Number of Common Shares (in thousands):
Basic	359,686		359,400		359,653		359,329
Effect of restricted stock and performance shares	736		589		677		570
Diluted	360,422		359,989		360,330		359,899
Earnings per Common Share Attributable to Common Shareholders of CME Group:
Basic	$	2.49	$	2.51	$	7.93	$	7.29
Diluted	2.49		2.50		7.92		7.27

13. Segment Reporting

The company's business is conducted through one reportable business segment, CME Group consolidated. The company has one operating segment as this is the level at which resource allocation and operating decisions regarding company performance are evaluated and determined by the senior leadership team.

The chief operating decision maker (CODM) reviews the financial results of CME Group consolidated on an ongoing basis throughout the year. As a single segment, the segment profitability measure is consolidated net income. Consolidated net income informs key operating decisions as made by the CODM, which include bonus allocation, discretionary share-based awards, liquidity and cash needs, new product development, existing product expansion and product discontinuation. Consolidated net income is deemed the best indicator of segment performance. Segment assets are not reported to, or used by, the CODM to allocate resources or to assess performance.

The CODM evaluates current period consolidated net income performance as compared to prior periods, budgeted results and forecasts. The CODM reviews consolidated revenues as disaggregated by the following: clearing and transaction fees as a combination of rate per contract and average daily volume for each major asset class, market data fee revenue and other revenue. The significant expense categories are consistent with those presented on the face of the consolidated statements of income. The components of non-operating income are also reviewed by the CODM. It is noted that the level of financial information provided to the CODM is consistent with the financial statement line items as disclosed in our consolidated statements of income.

Table of Contents

14. Subsequent Events

The company has evaluated subsequent events through the date the financial statements were issued. On October 10, 2025, S&P Global and CME Group completed the sale of OSTTRA, our 50% equity method investment, to investment funds managed by KKR & Co. Inc. OSTTRA is a provider of post-trade solutions for the over the counter market. The carrying amount of the company's investment in OSTTRA was $1.2 billion at September 30, 2025 and was included in other assets on the consolidated balance sheets. The total enterprise value of OSTTRA was $3.1 billion, which will be divided evenly between S&P Global and CME Group pursuant to the 50/50 joint venture. The company expects to recognize a net gain of approximately $300.0 million in the fourth quarter of 2025.

Table of Contents


ITEM 2.			MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion is provided as a supplement to, and should be read in conjunction with, the accompanying unaudited consolidated financial statements and notes in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 27, 2025.

References in this discussion and analysis to “we” and “our” are to CME Group Inc. (CME Group) and its consolidated subsidiaries, collectively. References to “exchange” are to Chicago Mercantile Exchange Inc. (CME), the Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX), and Commodity Exchange, Inc. (COMEX), collectively, unless otherwise noted.

RESULTS OF OPERATIONS

Financial Highlights

The following summarizes significant changes in our financial performance for the periods presented.


	Quarter Ended September 30,								Nine Months Ended September 30,
(dollars in millions, except per share data)	2025			2024			Change		2025			2024			Change
Total revenues	$	1,537.6		$	1,584.4		(3)	%	$	4,871.9		$	4,604.8		6	%
Total expenses	565.0			560.2			1		1,662.0			1,620.4			3
Operating margin	63.3		%	64.6		%			65.9		%	64.8		%
Non-operating income (expense)	$	204.4		$	152.7		34		$	542.2		$	460.4		18
Effective tax rate	22.9		%	22.4		%			23.0		%	23.0		%
Net income	$	908.0		$	912.8		(1)		$	2,889.3		$	2,651.2		9
Diluted earnings per common share	2.49			2.50			—		7.92			7.27			9
Cash flows from operating activities									3,143.2			2,672.6			18

Revenues


	Quarter Ended September 30,						Nine Months Ended September 30,
(dollars in millions)	2025		2024		Change		2025		2024		Change
Clearing and transaction fees	$	1,227.9	$	1,297.1	(5)	%	$	3,953.2	$	3,755.9	5	%
Market data and information services	202.5		178.2		14		595.1		528.6		13
Other	107.2		109.1		(2)		323.6		320.3		1
Total Revenues	$	1,537.6	$	1,584.4	(3)		$	4,871.9	$	4,604.8	6

Clearing and Transaction Fees

Futures and Options Contracts

The following table summarizes our total contract volume, revenue and average rate per contract for futures and options. Total contract volume includes contracts that are traded on our exchange and cleared through our clearing house and certain cleared-only contracts. Volume is measured in round turns, which is considered a completed transaction that involves a purchase and an offsetting sale of a contract. Average rate per contract is determined by dividing total clearing and transaction fees by total contract volume. Contract volume and average rate per contract disclosures exclude trading volume for the cash markets business and interest rate swaps volume.


	Quarter Ended September 30,						Nine Months Ended September 30,
	2025		2024		Change		2025		2024		Change
Total contract volume (in millions)	1,620.6		1,810.5		(10)	%	5,309.8		5,052.8		5	%
Clearing and transaction fees (in millions)	$	1,137.6	$	1,205.3	(6)		$	3,675.9	$	3,479.3	6
Average rate per contract	$	0.702	$	0.666	5		$	0.692	$	0.689	1

Table of Contents

We estimate the following net changes in clearing and transaction fees based on the changes in total contract volumes and the changes in average rate per contract for futures and options during the third quarter and first nine months of 2025 when compared with the same periods in 2024.


(in millions)	Quarter Ended		Nine Months Ended
Increase (decrease) due to changes in total contract volume	$	(133.4)	$	178.0
Increases due to changes in average rate per contract	65.7		18.6
Net increase (decrease) in clearing and transaction fees	$	(67.7)	$	196.6

Average rate per contract is impacted by our rate structure, including volume-based incentives; product mix; trading venue; and the percentage of volume executed by customers who are members compared with non-member customers. Due to the relationship between average rate per contract and contract volume, the change in clearing and transaction fees attributable to changes in each is only an approximation.

Contract Volume

The following table summarizes average daily contract volume. Contract volume can be influenced by many factors, including political and economic conditions, the regulatory environment and market competition.


	Quarter Ended September 30,						Nine Months Ended September 30,
(amounts in thousands)	2025		2024		Change		2025		2024		Change
Average Daily Volume by Product Line:
Interest rates	13,378		14,881		(10)	%	14,611		13,877		5	%
Equity indexes	6,278		7,407		(15)		7,297		7,018		4
Foreign exchange	834		1,088		(23)		1,024		1,050		(3)
Agricultural commodities	1,712		1,614		6		1,876		1,696		11
Energy	2,295		2,571		(11)		2,754		2,478		11
Metals	825		728		13		833		758		10
Aggregate average daily volume	25,322		28,289		(10)		28,395		26,877		6
Average Daily Volume by Venue:
CME Globex	23,418		26,199		(11)		26,377		24,792		6
Open outcry	989		1,096		(10)		955		1,082		(12)
Privately negotiated	915		994		(8)		1,063		1,003		6
Aggregate average daily volume	25,322		28,289		(10)		28,395		26,877		6
Electronic Volume as a Percentage of Total Volume	92	%	93	%			93	%	92	%

Market uncertainty remained high through the first half of 2025. Interest rate, equity and foreign exchange markets experienced significant uncertainty surrounding the economic impacts of anticipated and implemented tariffs and the effect they may have on the United States Federal Reserve’s (Federal Reserve) interest rate policy decision. In addition, market uncertainty also remained high within the energy, metals and agricultural commodities markets in the first half of 2025, mainly as a result of new and existing geopolitical tensions, including the anticipation and implementation of tariffs, as well as uncertain weather conditions in 2025. However, in the third quarter of 2025, overall market volatility subsided relative to periods of very high volatility earlier in the year as market uncertainty tapered as a result of consistent inflation data and more clarity surrounding the Federal Reserve's interest rate policy decision. We believe these factors contributed to an increase in volume in the first nine months of 2025 when compared with the same periods in 2024 and lower volume in the third quarter of 2025.

Table of Contents

Interest Rate Products

The following table summarizes average daily contract volume for our key interest rate products.


	Quarter Ended September 30,				Nine Months Ended September 30,
(amounts in thousands)	2025	2024	Change		2025	2024	Change
SOFR futures and options:
Futures expiring within two years	2,725	3,044	(10)	%	3,001	2,676	12	%
Options	1,560	1,790	(13)		1,456	1,661	(12)
Futures expiring beyond two years	962	1,069	(10)		1,111	954	16
U.S. Treasury futures and options:
10-Year	2,817	3,376	(17)		3,319	3,279	1
5-Year	1,900	2,088	(9)		2,124	2,014	6
2-Year	1,058	1,142	(7)		1,126	1,045	8
Treasury Bond	684	699	(2)		774	701	10
Ultra T-Note	662	668	(1)		750	669	12
Ultra T-Bond	416	427	(3)		438	421	4
Federal Funds futures and options	555	529	5		468	414	13

In the third quarter of 2025, interest rate contract volume was lower compared to the same period in 2024, due to lower overall market volatility. We believe the lower volatility was a result of more clarity surrounding the Federal Reserve's interest rate policy decision as well as consistent trends in inflation data.

Overall interest rate contract volume increased in the first nine months of 2025 when compared with the same period in 2024, due to higher overall volatility in early 2025. We believe this was due to market uncertainty surrounding the Federal Reserve's interest rate policy decision as well as mixed inflation data in the first half of 2025. In addition, new and existing geopolitical tensions as well as the potential economic impacts of anticipated and implemented tariffs also led to higher overall volatility in the first half of 2025. We believe these factors contributed to higher overall interest rate volume in the first nine months of 2025 when compared with the same period in 2024.

Equity Index and Cryptocurrency Products

The following table summarizes average daily contract volume for our key equity index and cryptocurrency products.


	Quarter Ended September 30,				Nine Months Ended September 30,
(amounts in thousands)	2025	2024	Change		2025	2024	Change
E-mini S&P 500 futures and options	3,454	4,320	(20)	%	4,099	4,136	(1)	%
E-mini Nasdaq 100 futures and options	1,888	2,277	(17)		2,293	2,127	8
E-mini Russell 2000 futures and options	272	337	(19)		300	319	(6)
E-mini Dow futures and options	176	262	(33)		228	247	(7)
Ether futures and options	239	46	n.m.		146	36	n.m.
Bitcoin futures and options	86	59	45		92	53	72

_________

n.m. not meaningful

Equity index contract volume decreased in the third quarter of 2025 when compared with the same period in 2024 due to lower overall equity market volatility. We believe lower market volatility was a result of less uncertainty surrounding the Federal Reserve's interest rate policy decision as well as consistent trends in inflation data.

Overall equity index contract volume increased in the first nine months of 2025 when compared with the same period in 2025, due to higher overall volatility in early 2025. We believe this was due to new and existing geopolitical tensions as well as the potential economic impacts of anticipated and implemented tariffs in the first half of 2025.

In addition, we believe volumes for our cryptocurrency products were higher as a result of the broader acceptance of cryptocurrency products.

Table of Contents

Foreign Exchange Products

The following table summarizes average daily contract volume for our key foreign exchange products.


	Quarter Ended September 30,				Nine Months Ended September 30,
(amounts in thousands)	2025	2024	Change		2025	2024	Change
Euro	223	257	(13)	%	267	257	4	%
Japanese Yen	156	227	(31)		192	201	(5)
British Pound	93	126	(26)		110	123	(10)
Australian dollar	86	125	(31)		106	119	(11)
Canadian dollar	66	105	(37)		96	104	(7)

In the third quarter and first nine months of 2025, overall foreign exchange volumes decreased when compared with the same periods in 2024 due to lower market volatility. We believe this was the result of less uncertainty surrounding the global central bank's interest rate policies as well as consistent trends in inflation data, which has led to overall decreases in foreign exchange contract volumes.

Agricultural Commodity Products

The following table summarizes average daily contract volume for our key agricultural commodity products.


	Quarter Ended September 30,				Nine Months Ended September 30,
(amounts in thousands)	2025	2024	Change		2025	2024	Change
Corn	493	481	2	%	583	509	14	%
Soybean	347	329	6		373	352	6
Wheat	206	196	5		246	234	5

Overall commodity contract volumes increased in the third quarter and first nine months of 2025 when compared with the same periods in 2024. We believe these increases were due to higher overall market volatility as a result of uncertainty surrounding the potential economic impacts of anticipated and implemented tariffs as they relate to the commodities market. In addition, changes in market expectations regarding grain supplies as well as uncertain weather conditions in 2025 also led to increases in volumes. We believe these factors contributed to higher overall commodity volumes in the third quarter and first nine months of 2025 compared with the same periods in 2024.

Energy Products

The following table summarizes average daily contract volume for our key energy products.


	Quarter Ended September 30,				Nine Months Ended September 30,
(amounts in thousands)	2025	2024	Change		2025	2024	Change
WTI crude oil	1,018	1,290	(21)	%	1,251	1,185	5	%
Natural gas	745	723	3		893	780	15
Refined products	358	388	(8)		406	383	6

Energy contract volume decreased in the third quarter 2025 when compared with the same period in 2024, which we believe was due to lower overall market volatility. Crude oil volatility subsided as a result of easing geopolitical tensions in the Middle East as well as more clarity surrounding global trade negotiations.

Overall energy contract volume increased in the first nine months of 2025 when compared with the same period in 2024, due to higher overall volatility. In the first half of 2025, crude oil volatility was higher as a result of geopolitical tensions across the globe, a shift in global supply levels, and the potential economic impacts of anticipated and implemented tariffs. Natural gas volatility was higher as a result of uncertain weather conditions and a shift in supplies in the United States in 2025, which impacted prices throughout the year. We believe these factors contributed to higher overall energy volume in the first nine months of 2025 compared with the same periods in 2024.

Table of Contents

Metal Products

The following table summarizes average daily volume for our key metal products.


	Quarter Ended September 30,				Nine Months Ended September 30,
(amounts in thousands)	2025	2024	Change		2025	2024	Change
Gold	577	447	29	%	571	436	31	%
Silver	116	119	(3)		112	127	(12)
Copper	78	113	(31)		96	145	(34)

In the third quarter and first nine months of 2025, overall metal contract volumes increased when compared with the same periods in 2024. We believe gold volumes increased as a result of increased price volatility caused by investors using gold as a safe-haven alternative investment due to uncertainty in other markets. The decreases in silver and copper volumes are due to reductions in demand for the metals due to economic instability as well as risk aversion by traders. We believe these factors contributed to higher overall metals volumes in the third quarter and first nine months of 2025 compared with the same periods in 2024.

Average Rate per Contract

The average rate per contract increased in the third quarter and first nine months of 2025 when compared with the same periods in 2024. The increases in the average rate per contract were primarily due to higher commodities, energy and metals contract volumes as a percentage of total volumes. In addition, the overall increases in average rate per contract were due to an increase in our fee structure, which went into effect on February 1, 2025.

Cash Markets Business

Total clearing and transaction fees revenues in the third quarter and first nine months of 2025 include $69.8 million and $215.4 million, respectively, of transaction fees attributable to the cash markets business, compared with $68.5 million and $207.9 million, respectively, in the third quarter and first nine months of 2024. This revenue includes BrokerTec Americas LLC's fixed income volume and EBS's foreign exchange volume.


	Quarter Ended September 30,						Nine Months Ended September 30,
(amounts in millions)	2025		2024		Change		2025		2024		Change
BrokerTec fixed income transaction fees	$	39.3	$	33.3	18	%	$	112.2	$	108.9	3	%
EBS foreign exchange transaction fees	30.5		35.2		(13)		103.2		99.0		4

The related average daily notional value for the third quarter and first nine months of 2025 and 2024 were as follows:


	Quarter Ended September 30,						Nine Months Ended September 30,
(amounts in billions)	2025		2024		Change		2025	2024		Change
U.S. Repo	$	379.4	$	297.2	28	%	358.3	$	292.7	22	%
European Repo (in euros)	292.1		285.9		2		309.4	289.5		7
U.S. Treasury	83.8		109.3		(23)		103.0	102.1		1
Spot FX	56.6		67.0		(16)		67.0	58.9		14

Overall average daily notional values for the cash markets business were higher in the third quarter and first nine months of 2025 when compared with the same periods in 2024 due to higher overall U.S. debt issuances. U.S. debt issuances were significantly higher in the third quarter and first nine months of 2025 as a result of the increase of the debt ceiling in early 2025, which resulted in an increase in U.S. Repo volumes. The increase in the third quarter of 2025 was partially offset by lower volatility within our U.S. Treasury products, as a result of more clarity surrounding the Federal Reserve's interest rate policy decision as well as consistent trends in inflation data.

Table of Contents

Concentration of Revenue

We bill a substantial portion of our clearing and transaction fees directly to our clearing firms. The majority of clearing and transaction fees received from clearing firms represent charges for trades executed and cleared on behalf of their customers. One individual firm represented at least 10% of our clearing and transaction fees in the first nine months of 2025. Should a clearing firm withdraw, we believe that the customer portion of the firm’s trading activity would likely transfer to another clearing firm of the exchange. Therefore, we do not believe we are exposed to significant risk from the ongoing loss of revenue received from or through a particular clearing firm.

Other Sources of Revenue

Market data and information services. During the third quarter and first nine months of 2025, overall market data and information services revenues increased when compared with the same periods in 2024, largely due to price increases for certain products as well as higher usage of certain products.

The two largest resellers of our market data represented approximately 31% of our market data and information services revenue in the first nine months of 2025. Despite this concentration, we consider exposure to significant risk of revenue loss to be minimal. In the event that one of these vendors no longer subscribes to our market data, we believe the majority of that vendor’s customers would likely subscribe to our market data through another reseller. Additionally, several of our largest institutional customers that utilize services from our two largest resellers report usage and remit payment of their fees directly to us.

Expenses


	Quarter Ended September 30,						Nine Months Ended September 30,
(dollars in millions)	2025		2024		Change		2025		2024		Change
Compensation and benefits	$	237.6	$	218.8	9	%	$	665.9	$	629.5	6	%
Technology	71.4		66.6		7		208.0		190.1		9
Professional fees and outside services	36.7		31.0		19		102.6		98.8		4
Amortization of purchased intangibles	56.2		55.7		1		167.5		166.4		1
Depreciation and amortization	26.4		28.2		(6)		81.0		87.0		(7)
Licensing and other fee agreements	81.6		97.6		(16)		274.4		271.4		1
Other	55.1		62.3		(11)		162.6		177.2		(8)
Total Expenses	$	565.0	$	560.2	1		$	1,662.0	$	1,620.4	3

Operating expenses increased by $4.8 million and $41.6 million, respectively, in the third quarter and first nine months of 2025 when compared with the same periods in 2024. The following table shows the estimated impacts of key factors resulting in the changes in operating expenses:


	Quarter Ended September 30, 2025				Nine Months Ended September 30,
	Amount of Change		Change as a Percentage of Total Expenses		Amount of Change		Change as a Percentage of Total Expenses
(dollars in millions)
Salaries, benefits and employer taxes	$	6.5	1	%	$	27.5	2	%
Technology support services	5.8		1		18.1		1
Legal fees	10.0		2		17.3		1
Google Cloud professional fees	(3.2)		(1)		(10.5)		(1)
Rent expense	(0.4)		—		(14.7)		(1)
Other expenses, net	(13.9)		(2)		3.9		1
Total increase	$	4.8	1	%	$	41.6	3	%

Increases in operating expenses in the third quarter and first nine months of 2025 when compared with the same periods in 2024 were as follows:

•Salaries, benefits and employer taxes expenses were higher as a result of salary increases that went into effect during the first quarter of 2025 as well as an increase in headcount during 2025, which was primarily attributable to additional headcount in the company's international locations.

Table of Contents

•The increases in technology support services expenses were primarily driven by higher software license fees and third party services to support the ongoing Google Cloud transformation project.

•Legal fees were higher primarily due to the class action lawsuit litigation in the second and third quarter of 2025.

Decreases in operating expense in the third quarter and first nine months when compared with the same periods in 2024 were as follows:

•The decreases in professional fees related to the Google Cloud transformation project, which began in late 2021, were the result of a shift in need from an overall project consulting focus to a technology migration focus.

•Rent expenses decreased during the third quarter and first nine months of 2025 largely due to gains of $10.5 million recognized in the second quarter of 2025 resulting from a reduction in our leased office space.

Non-Operating Income (Expense)


	Quarter Ended September 30,						Nine Months Ended September 30,
(dollars in millions)	2025		2024		Change		2025		2024		Change
Investment income	$	1,548.7	$	1,026.8	51	%	$	3,959.8	$	3,142.6	26	%
Interest and other borrowing costs	(44.0)		(40.2)		9		(129.7)		(120.2)		8	%
Equity in net earnings of unconsolidated subsidiaries	96.3		86.1		12		283.5		259.7		9
Other non-operating income (expense)	(1,396.6)		(920.0)		52		(3,571.4)		(2,821.7)		27
Total Non-Operating	$	204.4	$	152.7	34		$	542.2	$	460.4	18

Investment income. Earnings from cash performance bond and guaranty fund contributions that are reinvested increased in the third quarter and first nine months of 2025 when compared with the same periods in 2024 due to higher reinvestment balances, despite decreases in the average rate of return on the reinvestment balances. In the third quarter and first nine months of 2025, earnings from cash performance bond and guaranty fund contributions were $1,514.1 million and $3,875.3 million, respectively, compared with $991.3 million and $3,035.6 million, respectively, in the third quarter and first nine months of 2024. We also recognized lower net realized and unrealized gains on investments in the third quarter and first nine months of 2025.

Equity in net earnings (losses) of unconsolidated subsidiaries. Higher income generated from our S&P Dow Jones Indices LLC business venture contributed to increases in equity in net earnings (losses) of unconsolidated subsidiaries in the third quarter and first nine months of 2025 when compared with 2024.

Other non-operating income (expense). We recognized higher expenses related to the distribution of interest earned on performance bond collateral reinvestments to the clearing firms during the third quarter and first nine months of 2025 when compared with the same periods in 2024. In the third quarter and first nine months of 2025, expenses related to the distribution of interest earned on collateral reinvestments were $1,399.2 million and $3,578.5 million, respectively, compared with $922.6 million and $2,829.4 million, respectively, in the third quarter and first nine months of 2024.

Income Tax Provision

The following table summarizes the effective tax rates for the periods presented:


	2025		2024
Quarter ended September 30	22.9	%	22.4	%
Nine months ended September 30	23.0		23.0

The overall effective tax rates remained relatively consistent in the third quarter and first nine months of 2025 when compared with the same periods in 2024.

Liquidity and Capital Resources

Sources and Uses of Cash. Net cash provided by operating activities increased in the first nine months of 2025 when compared with the same period in 2024, which was largely due to an increase in trading volume and higher interest earned on reinvestment of collateral, net of distributions. Cash used in investing activities remained relatively consistent in the first nine months of 2025 when compared with the same period in 2024. Cash provided by financing activities was higher during the first nine months of 2025 when compared with the same period in 2024 due to an increase in cash performance bonds and guaranty fund contributions.

Table of Contents

Debt Instruments. The following table summarizes our debt outstanding at September 30, 2025:


(in millions)	Par Value
Fixed rate notes due June 2028, stated rate of 3.75%	$	500.0
Fixed rate notes due March 2030, stated rate of 4.40%	750.0
Fixed rate notes due March 2032, stated rate of 2.65%	750.0
Fixed rate notes due September 2043, stated rate of 5.30% (1)	750.0
Fixed rate notes due June 2048, stated rate of 4.15%	700.0

_______________

(1)We maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable effectively became fixed at a rate of 4.73%.

We maintain a $2.3 billion multi-currency revolving senior credit facility with various financial institutions, which matures in April 2030. The proceeds from this facility can be used for general corporate purposes, which includes providing liquidity for our clearing house in certain circumstances at CME Group's discretion and, if necessary, for maturities of commercial paper. As long as we are not in default under this facility, we have the option to increase it up to $3.3 billion with the consent of the agent and lenders providing the additional funds. This facility is voluntarily pre-payable from time to time without premium or penalty. Under this facility, we are required to remain in compliance with a consolidated net worth test, which is defined as our consolidated shareholders' equity at December 31, 2024, giving effect to share repurchases made and special dividends paid during the term of the agreement (and in no event greater than $2.0 billion in aggregate), multiplied by 0.65. We currently do not have any borrowings outstanding under this facility, but any commercial paper balance if or when outstanding can be backstopped against this facility.

We maintain a 364-day multi-currency revolving secured credit facility with a consortium of domestic and international banks to be used in certain situations by the clearing house. The facility provides for borrowings of up to $7.0 billion. We may use the proceeds to provide temporary liquidity in the unlikely event a clearing firm fails to promptly discharge an obligation to the clearing house operated by CME, in the event of a liquidity constraint or default by a depositary (custodian for our collateral), in the event of a temporary disruption with the domestic payments system that would delay payment of settlement variation between us and our clearing firms, or in other cases as provided by the CME rulebook. Clearing firm guaranty fund contributions received in the form of cash or U.S. Treasury securities as well as the performance bond assets (pursuant to the CME rulebook) can be used to collateralize the facility. At September 30, 2025, guaranty fund contributions available to collateralize the facility totaled $9.5 billion. We have the option to increase the line from $7.0 billion to $10.0 billion with the consent of the agent and lenders providing the additional funds. Our 364-day facility contains a requirement that CME remain in compliance with a consolidated tangible net worth test, defined as CME's consolidated shareholder's equity less intangible assets (as defined in the agreement), of not less than $800.0 million. We currently do not have any borrowings outstanding under this facility.

The indentures governing our fixed rate notes, our $2.3 billion multi-currency revolving senior credit facility and our 364-day multi-currency revolving secured credit facility for $7.0 billion do not contain specific covenants that restrict the ability to pay dividends. These documents, however, do contain other customary financial and operating covenants that place restrictions on the operations of the company that could indirectly affect the ability to pay dividends.

At September 30, 2025, we have excess borrowing capacity for general corporate purposes of approximately $2.3 billion under our multi-currency revolving senior credit facility.

We maintain committed repurchase facility agreements amounting to a total of $1.0 billion. The committed repurchase facilities provide access to cash, secured by non-cash collateral, in the event that one or more of our clearing firms fails to promptly discharge an obligation to the clearing house. The facilities are subject to annual renewal. We currently do not have any borrowings outstanding under these facilities.

We maintain a committed facility of up to $750.0 million for foreign currency conversions. The committed foreign currency facility allows the clearing house to convert cash to another currency within generally accepted local market timeframes in the event that one or more of our clearing firms fails to promptly discharge an obligation to the clearing house. The facility is subject to annual renewal. We currently do not have any foreign currency trades outstanding under this facility.

At September 30, 2025, we were in compliance with the various covenant requirements of all our debt facilities.

CME Group, as a holding company, has no operations of its own. Instead, it relies on dividends declared and paid to it by its subsidiaries in order to provide the funds which it uses to pay dividends to its shareholders.

Table of Contents

To satisfy our performance bond obligation with Singapore Exchange Limited, we may pledge irrevocable standby letters of credit. At September 30, 2025, the letters of credit totaled $400.0 million. We also maintain a $350.0 million line of credit to meet our obligations under this agreement.

The following table summarizes our credit ratings at September 30, 2025:

Short-Term

Long-Term

Rating Agency

Debt Rating

Outlook

Standard & Poor’s Global Ratings

A1+

AA-

Stable

Moody’s Investors Service, Inc.

Aa3

Stable

Given our cash flow generation, our ability to pay down debt levels and our ability to refinance existing debt facilities if necessary, we expect to maintain an investment grade rating. If our ratings are downgraded below investment grade within certain specified time periods due to a change of control, we are required to make an offer to repurchase our fixed rate notes at a price equal to 101% of the principal amount, plus accrued and unpaid interest. No report of any rating agency is incorporated by reference herein.

Liquidity and Cash Management. Cash and cash equivalents totaled $2.4 billion and $2.9 billion at September 30, 2025 and December 31, 2024, respectively. The balance retained in cash and cash equivalents is a function of anticipated or possible short-term cash needs, prevailing interest rates, our corporate investment policy and alternative investment choices. A majority of our cash and cash equivalents balance is invested in money market mutual funds that invest only in U.S. Treasury securities, U.S. government agency securities and U.S. Treasury security reverse repurchase agreements and short-term bank deposits. Our exposure to credit and liquidity risk is minimal given the nature of the investments. Cash that is not available for general corporate purposes because of regulatory requirements or other restrictions is classified as restricted cash and is included in cash performance bonds and guaranty fund contributions, other current assets or other assets in the consolidated balance sheets.

On December 5, 2024, we announced that our board of directors has approved a share repurchase program under which we are authorized to repurchase up to $3.0 billion of our outstanding Class A common stock, par value $0.01 per share (the common stock), from time to time through open market transactions, block trades, privately negotiated purchase transactions or other purchase techniques and may include purchases effected pursuant to one or more trading plans established pursuant to Rule 10b5-1 under the Exchange Act. The timing of any repurchases and the number of shares repurchased under the share repurchase program are within our discretion and may be affected by various factors, including general market and economic conditions; the market price of the common stock; CME Group’s earnings, financial condition, capital requirements and levels of indebtedness; legal requirements; and other considerations. The share repurchase program has no expiration date, does not obligate us to acquire any particular amount of common stock and may be modified, suspended or terminated at any time. As of September 30, 2025, the maximum remaining value of shares to be repurchased was $2,991.8 million.

Regulatory Requirements. CME is regulated by the CFTC as a Derivatives Clearing Organization (DCO). DCOs are required to maintain capital, as defined by the CFTC, in an amount at least equal to one year of projected operating expenses as well as cash, liquid securities, or a line of credit at least equal to six months of projected operating expenses. CME was designated by the Financial Stability Oversight Council as a systemically important financial market utility under Title VIII of the Dodd-Frank Wall Street Reform and Consumer Protection Act. As a result, CME must comply with CFTC regulations applicable to a systemically important DCO for financial resources and liquidity resources. CME is in compliance with all DCO financial requirements.

CME, CBOT, NYMEX and COMEX are regulated by the CFTC as Designated Contract Markets (DCM). DCMs are required to maintain capital, as defined by the CFTC, in an amount at least equal to one year of projected operating expenses as well as cash, liquid securities or a line of credit at least equal to six months of projected operating expenses. Our DCMs are in compliance with all DCM financial requirements.

BrokerTec Americas LLC is required to maintain sufficient net capital under Securities Exchange Act of 1934, as amended (Exchange Act), Rule 15c3-1 (the Net Capital Rule). The Net Capital Rule focuses on liquidity and is designed to protect securities customers, counterparties, and creditors by requiring that broker-dealers have sufficient liquid resources on hand at all times to satisfy claims promptly. Rule 15c3-3, or the customer protection rule, which complements Rule 15c3-1, is designed to ensure that customer property (securities and funds) in the custody of broker-dealers is adequately safeguarded. By law, both of these rules apply to the activities of registered broker-dealers, but not to unregistered affiliates. The firm began operating as a (k)(2)(i) broker dealer in November 2017 following notification to the Financial Industry Regulatory Authority and the SEC. A company operating under the (k)(2)(i) exemption is not required to lock up customer funds as would otherwise be required under Exchange Act Rule 15c3-3.

Table of Contents


ITEM 3.			QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are subject to various market risks, including those caused by changes in interest rates, credit, foreign currency exchange rates and equity prices. There have not been material changes in our exposure to market risk since December 31, 2024. Refer to Item 7A. of CME Group’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 27, 2025, for additional information.


ITEM 4.			CONTROLS AND PROCEDURES

(a) Disclosure Controls and Procedures. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, our disclosure controls and procedures are effective.

(b) Changes in Internal Control Over Financial Reporting. As required by Rule 13a-15(d) under the Exchange Act, the company’s management, including the company’s Chief Executive Officer and Chief Financial Officer, have evaluated the company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) to determine whether any changes occurred during the quarter covered by this quarterly report that have materially affected, or are reasonably likely to materially affect, the company’s internal control over financial reporting. There were no changes in the company’s internal control over financial reporting which occurred during the fiscal quarter ended September 30, 2025, that have materially affected, or are reasonably likely to materially affect, the company’s internal control over financial reporting.

PART II. OTHER INFORMATION


ITEM 1.			LEGAL PROCEEDINGS

The disclosure under “Legal and Regulatory Matters” in Note 6. Contingencies in the Notes to Unaudited Consolidated Financial Statements in Item 1 of Part I of this report is incorporated herein by reference. Such disclosure includes updates to the legal proceedings disclosed in the company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 27, 2025.


ITEM 1A.			RISK FACTORS

There have been no material changes in the company's risk factors from those disclosed in the company's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 27, 2025.


ITEM 2.			UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities


Period	Total Number of Class A Shares Purchased		Average Price Paid per Share		Total Number of Class A Shares Purchased as Part of Publicly Announced Plans or Programs (1)	Maximum Approximate Value of Shares That May Yet Be Purchased Under the Plans or Programs(1) (in millions)
July 1 to July 31	58		$	274.64	—	$	2,991.8
August 1 to August 31	3,860		273.91		—	2,991.8
September 1 to September 30	83,585		259.14		—	2,991.8
Total	87,503	(2)			—

(1)On December 5, 2024, CME Group announced that its board of directors approved a share repurchase program under which CME Group is authorized to repurchase up to $3.0 billion of its outstanding Class A common stock, par value $0.01 per share (the common stock). The share repurchase program has no expiration date.

(2)Shares purchased consist of shares surrendered to satisfy employee tax obligations upon the vesting of restricted stock.


ITEM 5.			OTHER INFORMATION

During the quarter ended September 30, 2025, no director or officer of the company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b-5 trading arrangement" as such terms are defined in Item 408(a) of Regulation S-K.

Table of Contents


ITEM 6.			EXHIBITS










31.1						Section 302 Certification—Terrence A. Duffy

31.2						Section 302 Certification—Lynne Fitzpatrick

32.1						Section 906 Certification

101						The following materials from CME Group Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, formatted in Inline XBRL (Xtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Equity, (v) the Consolidated Statements of Cash Flows and (vi) Notes to Unaudited Consolidated Financial Statements, tagged as blocks of text.

104						Cover Page Interactive Data File included in the Inline XBRL Document Set for Exhibit 101.

101.DEF						XBRL Taxonomy Extension Definition Linkbase

101.LAB						XBRL Taxonomy Extension Label Linkbase Document

101.PRE						XBRL Taxonomy Extension Presentation Linkbase Document

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CME Group Inc.

(Registrant)

Dated: October 24, 2025

By:

/s/ Lynne Fitzpatrick

Lynne Fitzpatrick

Senior Managing Director, President and Chief Financial Officer

Principal Financial Offer and
Duly Authorized Officer

Source: View Original Filing on SEC EDGAR

FAQ

What were CME (CME) Q3 2025 revenue and EPS?

Revenue was $1,537.6 million; diluted EPS was $2.49.

How did CME's revenue mix change in Q3 2025?

Clearing and transaction fees were $1,227.9 million (down year over year), while market data grew to $202.5 million (up 14%).

What was CME’s operating margin in Q3 2025?

Operating margin was 63.3% on operating income of $972.6 million.

How much operating cash flow did CME generate year-to-date 2025?

Net cash provided by operating activities was $3,143.2 million for the nine months ended September 30, 2025.

What capital returns did CME make in 2025 so far?

Dividends totaled $3.75 per share YTD; CME repurchased 32,265 shares for $8.2 million.

What is CME’s current debt profile?

Long‑term debt was $3,421.3 million. CME retired $750.0 million due 2025 and issued $750.0 million due 2030.

What is the status of the OSTTRA transaction?

On October 10, 2025, CME completed the sale of OSTTRA (EV $3.1 billion split 50/50) and expects a ~$300.0 million gain in Q4.

[10-Q] CME GROUP INC. Quarterly Earnings Report

Insights

FAQ

What were CME (CME) Q3 2025 revenue and EPS?

How did CME's revenue mix change in Q3 2025?

What was CME’s operating margin in Q3 2025?

How much operating cash flow did CME generate year-to-date 2025?

What capital returns did CME make in 2025 so far?

What is CME’s current debt profile?

What is the status of the OSTTRA transaction?

NASDAQ:CME

CME Rankings

CME Latest News

CME Latest SEC Filings

CME Stock Data

Trending News

[10-Q] CME GROUP INC. Quarterly Earnings Report

Insights

Market structure and exchanges analyst neutral

FAQ

What were CME (CME) Q3 2025 revenue and EPS?

How did CME's revenue mix change in Q3 2025?

What was CME’s operating margin in Q3 2025?

How much operating cash flow did CME generate year-to-date 2025?

What capital returns did CME make in 2025 so far?

What is CME’s current debt profile?

What is the status of the OSTTRA transaction?

NASDAQ:CME

CME Rankings

CME Latest News

CME Latest SEC Filings

CME Stock Data